Cartesian Therapeutics Stock Quote RNAC - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

24.57

Bid

13.00

Ask

24.57

Volume

0.00 Day's Range 0.00

11.665 52 Week Range 42.60

Market Cap

3.979B

Previous Close

24.57

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

409,638

Shares Outstanding

161,948,618

Dividend Yield

PE Ratio

-18.11

Earnings Per Share (EPS)

-1.36

Revenue

26M

Net Profit

-219.71M

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.selectabio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was $24.57. Over the last year, Cartesian Therapeutics shares have traded in a share price range of $ 11.665 to $ 42.60.

Cartesian Therapeutics currently has 161,948,618 shares outstanding. The market capitalization of Cartesian Therapeutics is $3.98 billion. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -18.11.

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

GAITHERSBURG, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.26	-4.87804878049	25.83	28.93	23.51	90588	24.93440867	CS
4	2.87	13.2258064516	21.7	29.19	20.1	81646	24.56651836	CS
12	4.77	24.0909090909	19.8	29.19	11.665	409638	18.76440481	CS
26	-12.93	-34.48	37.5	40.5	11.665	597501	21.96993818	CS
52	0.375	1.54990700558	24.195	42.6	11.665	642128	23.43340794	CS
156	0.375	1.54990700558	24.195	42.6	11.665	642128	23.43340794	CS
260	0.375	1.54990700558	24.195	42.6	11.665	642128	23.43340794	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.3784 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.67 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.84 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.46 (0.00%)	0
AACGATA Creativity Global	$ 0.850101 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.3784 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.67 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.84 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.46 (0.00%)	0
AACGATA Creativity Global	$ 0.850101 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.3784 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.67 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.84 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.46 (0.00%)	0
AACGATA Creativity Global	$ 0.850101 (0.00%)	0